ArticleAnnals of hematology2021

Composite diffuse large B-cell and peripheral T-cell lymphoma with T-helper phenotype treated with both rituximab and brentuximab vedotin.

Kouichi Ohya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.